Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus

Table 3 Laboratory data and adipose tissue area with computed tomography in patients with T2DM

	Patients with T2DM (N=148)
Laboratory data
Creatinine, mg/dl	0.92 ± 0.17
eGFR, ml/min	83 ± 26
Triglyceride, mg/dl	139 ± 100
HDL cholesterol, mg/dl	50 ± 15
Total cholesterol, mg/dl	198 ± 34
F-LDL cholesterol, mg/dl	119 ± 32
Fasting plasma glucose, mg/dl	138 ± 38
Hemoglobin A1c, %	7.9 ± 1.4
NEFA, μEq/L	613 ± 202
IRI, μg/dl	8.7 ± 7.0
HOMA-R	2.9 ± 2.7
hsCRP, mg/dl	0.190 ± 0.357
NT-proBNP, pg/ml	36.2 ± 55.3
CPR, mg/dl	2.8 ± 9.6
Fat areas determined by CT scan
Total adipose tissue/BSA, cm²/m²	169.4 ± 74.9
Visceral adipose tissue/BSA, cm²/m²	68.3 ± 30.6
Subcutaneous adipose tissue/BSA, cm²/m²	101.1 ± 54.3

eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; F-LDL, low-density lipoprotein calculated by Friedewald; NEFA, non-esterified fatty acid; IRI, immunoreactive insulin; HOMA, homeostasis model assessment; hsCRP, high-sensitivity C reactive protein; NT-pro BNP, N-terminal pro b-type natriuretic peptide; CPR, C-peptide immunoreactivity; CT, computed tomography; BSA, body surface area.

ISSN: 1475-2840